SHAWNA HEAPS: Open Payments
NPI 1982252318 · SOUTH JORDAN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,878 in 80 payments from 12 companies in 2025. Trend: 2023 $994 · 2024 $1,623 · 2025 $1,878
Food & beverage: $1,806Education: $72
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 19 | $434 |
| REVANCE THERAPEUTICS, INC. | 5 | $329 |
| UCB, Inc. | 6 | $242 |
| Novartis Pharmaceuticals Corporation | 16 | $241 |
| Janssen Biotech, Inc. | 4 | $224 |
| ABBVIE INC. | 19 | $178 |
| PFIZER INC. | 3 | $57 |
| Lilly USA, LLC | 2 | $47 |
| Biofrontera Inc. | 2 | $43 |
| LEO Pharma Inc. | 2 | $39 |
Products named: DAXXIFY, Zoryve, Bimzelx, TREMFYA, COSENTYX, SKYRIZI, LITFULO, Rhapsido.
Industry payments across UT — which companies pay providers there.
